Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis 
and Disease Outcome

Duffy, Fergal J.; Weiner, January III; Hansen, Scott; Tabb, David L.; Suliman, Sara; Thompson, Ethan; Maertzdorf, Jeroen; Shankar, Smitha; Tromp, Gerard; Parida, Shreemanta K.; Dover, Drew; Axthelm, Michael K.; Sutherland, Jayne S.; Dockrell, Hazel M.; Ottenhoff, Tom H. M.; Scriba, Thomas J.; Picker, Louis J.; Walzl, Gerhard; Kaufmann, Stefan H. E.; Zak, Daniel E.

doi:10.3389/fimmu.2019.00527

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome

MPS-Authors

/persons/resource/persons82210

Weiner, January III
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82029

Maertzdorf, Jeroen
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82090

Parida, Shreemanta K.
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons81969

Kaufmann, Stefan H. E.
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

Front_Immunol_2019_10_527.pdf
(Publisher version), 4MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Duffy, F. J., Weiner, J. I., Hansen, S., Tabb, D. L., Suliman, S., Thompson, E., et al. (2019). Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome. Frontiers in immunology, 10: 527. doi:10.3389/fimmu.2019.00527.

Cite as: https://hdl.handle.net/21.11116/0000-0003-7D85-B

Abstract

There is no abstract available